| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA77920
Max Phase: Preclinical
Molecular Formula: C19H27N3O2
Molecular Weight: 329.44
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCCCCCc1ccc(Nc2cc(=O)[nH]c(=O)n2CCC)cc1
Standard InChI: InChI=1S/C19H27N3O2/c1-3-5-6-7-8-15-9-11-16(12-10-15)20-17-14-18(23)21-19(24)22(17)13-4-2/h9-12,14,20H,3-8,13H2,1-2H3,(H,21,23,24)
Standard InChI Key: DIVNBRJKAUOFFQ-UHFFFAOYSA-N
Associated Targets(Human)
Uracil-DNA glycosylase 29 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 329.44 | Molecular Weight (Monoisotopic): 329.2103 | AlogP: 3.81 | #Rotatable Bonds: 9 |
| Polar Surface Area: 66.89 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 9.96 | CX Basic pKa: 0.75 | CX LogP: 4.55 | CX LogD: 4.55 |
| Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.69 | Np Likeness Score: -0.69 |
References
| 1. Sun H, Zhi C, Wright GE, Ubiali D, Pregnolato M, Verri A, Focher F, Spadari S.. (1999) Molecular modeling and synthesis of inhibitors of herpes simplex virus type 1 uracil-DNA glycosylase., 42 (13): [PMID:10395474] [10.1021/jm980718d] |
Source
Source(1):